|
1
|
Togashi Y and Nishikawa H: Regulatory T
cells: Molecular and cellular basis for immunoregulation. Curr Top
Microbiol Immunol. 410:3–27. 2017.PubMed/NCBI
|
|
2
|
Vignali DA, Collison LW and Workman CJ:
How regulatory T cells work. Nat Rev Immunol. 8:523–532. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Collison LW, Chaturvedi V, Henderson AL,
Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ,
Brown SA, et al: IL-35-mediated induction of a potent regulatory T
cell population. Nat Immunol. 11:1093–1101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo H, Xun L, Zhang R and Gou X: Ratio of
CD147high/CD147low in
CD4+CD25+ T cells: A potential biomarker for
early diagnosis and prediction of response to therapy for
autoimmune diseases. Med Hypotheses. 115:1–4. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Talaat RM, Mohamed SF, Bassyouni IH and
Raouf AA: Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus
erythematosus (SLE) patients: Correlation with disease activity.
Cytokine. 72:146–153. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bluestone JA, Buckner JH, Fitch M,
Gitelman SE, Gupta S, Hellerstein MK, Herold KC, Lares A, Lee MR,
Li K, et al: Type 1 diabetes immunotherapy using polyclonal
regulatory T cells. Sci Transl Med. 7:315ra1892015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ou HX, Guo BB, Liu Q, Li YK, Yang Z, Feng
WJ and Mo ZC: Regulatory T cells as a new therapeutic target for
atherosclerosis. Acta Pharmacol Sin. 39:1249–1258. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martin-Moreno PL, Tripathi S and
Chandraker A: Regulatory T cells and kidney transplantation. Clin J
Am Soc Nephrol. 13:1760–1764. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qiu R, Zhou L, Ma Y, Zhou L, Liang T, Shi
L, Long J and Yuan D: Regulatory T cell plasticity and stability
and autoimmune diseases. Clin Rev Allergy Immunol. Nov
17–2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Alvarez C, Rojas C, Rojas L, Cafferata EA,
Monasterio G and Vernal R: Regulatory T lymphocytes in
periodontitis: A translational view. Mediators Inflamm 2018.
78069122018.
|
|
11
|
Sakaguchi S, Sakaguchi N, Asano M, Itoh M
and Toda M: Pillars article: Immunologic self-tolerance maintained
by activated T cells expressing IL-2 receptor α-chains (CD25).
Breakdown of a single mechanism of self-tolerance causes various
autoimmune diseases. J. Immunol. 1995. J Immunol. 186:3808–3821.
2011.PubMed/NCBI
|
|
12
|
Jeffery HC, Braitch MK, Brown S and Oo YH:
Clinical potential of regulatory T cell therapy in liver diseases:
An overview and current perspectives. Front Immunol. 7:3342016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lam AJ, Hoeppli RE and Levings MK:
Harnessing advances in T regulatory cell biology for cellular
therapy in transplantation. Transplantation. 101:2277–2287. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ait-Oufella H, Taleb S, Mallat Z and
Tedgui A: Recent advances on the role of cytokines in
atherosclerosis. Arterioscler Thromb Vasc Biol. 31:969–979. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fatkhullina AR, Peshkova IO and Koltsova
EK: The role of cytokines in the development of atherosclerosis.
Biochemistry (Mosc). 81:1358–1370. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Badal D, Kumar R, Paul M, Dayal D,
Bhansali A, Bhadada SK, Kumar R and Sachdeva N: Peripheral blood
mononuclear cells of patients with latent autoimmune diabetes
secrete higher levels of pro- & anti-inflammatory cytokines
compared to those with type-1 diabetes mellitus following in vitro
stimulation with β-cell autoantigens. Indian J Med Res.
145:767–776. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yao Y, Wang JB, Xin MM, Li H, Liu B, Wang
LL, Wang LQ and Zhao L: Balance between inflammatory and regulatory
cytokines in systemic lupus erythematosus. Genet Mol Res. 15:2016.
View Article : Google Scholar
|
|
18
|
He X, Smeets RL, van Rijssen E, Boots AM,
Joosten I and Koenen HJ: Single CD28 stimulation induces stable and
polyclonal expansion of human regulatory T cells. Sci Rep.
7:430032017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fan MY, Low JS, Tanimine N, Finn KK,
Priyadharshini B, Germana SK, Kaech SM and Turka LA: Differential
roles of IL-2 signaling in developing versus mature tregs. Cell
Rep. 25:1204–1213.e4. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baecher-Allan C, Brown JA, Freeman GJ and
Hafler DA: CD4+CD25high regulatory cells in human peripheral blood.
J Immunol. 167:1245–1253. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rubtsov YP, Niec RE, Josefowicz S, Li L,
Darce J, Mathis D, Benoist C and Rudensky AY: Stability of the
regulatory T cell lineage in vivo. Science. 329:1667–1671. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
de la Rosa M, Rutz S, Dorninger H and
Scheffold A: Interleukin-2 is essential for CD4+CD25+ regulatory T
cell function. Eur J Immunol. 34:2480–2488. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Levine AG, Arvey A, Jin W and Rudensky AY:
Continuous requirement for the TCR in regulatory T cell function.
Nat Immunol. 15:1070–1078. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guo H, Zheng M, Zhang K, Yang F, Zhang X,
Han Q, Chen ZN and Zhu P: Functional defects in CD4+ CD25high
FoxP3+ regulatory cells in ankylosing spondylitis. Sci Rep.
6:375592016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wells AD, Gudmundsdottir H and Turka LA:
Following the fate of individual T cells throughout activation and
clonal expansion. Signals from T cell receptor and CD28
differentially regulate the induction and duration of a
proliferative response. J Clin Invest. 100:3173–3183. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gudmundsdottir H, Wells AD and Turka LA:
Dynamics and requirements of T cell clonal expansion in vivo at the
single-cell level: Effector function is linked to proliferative
capacity. J Immunol. 162:5212–5223. 1999.PubMed/NCBI
|
|
27
|
Borsellino G, Kleinewietfeld M, Di Mitri
D, Sternjak A, Diamantini A, Giometto R, Höpner S, Centonze D,
Bernardi G, Dell'Acqua ML, et al: Expression of ectonucleotidase
CD39 by Foxp3+ Treg cells: Hydrolysis of extracellular ATP and
immune suppression. Blood. 110:1225–1232. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fontenot JD, Rasmussen JP, Gavin MA and
Rudensky AY: A function for interleukin 2 in Foxp3-expressing
regulatory T cells. Nat Immunol. 6:1142–1151. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li X and Zheng Y: Regulatory T cell
identity: Formation and maintenance. Trends Immunol. 36:344–353.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Passerini L and Bacchetta R:
Forkhead-box-P3 gene transfer in human CD4(+) T conventional cells
for the generation of stable and efficient regulatory T cells,
suitable for immune modulatory therapy. Front Immunol. 8:12822017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ezzelarab MB: Regulatory T cells from
allo- to xenotransplantation: Opportunities and challenges.
Xenotransplantation. 25:e124152018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Min B: Heterogeneity and stability in
Foxp3+ regulatory T cells. J Interferon Cytokine Res. 37:386–397.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tanaka T, Narazaki M and Kishimoto T: IL-6
in inflammation, immunity, and disease. Cold Spring Harb Perspect
Biol. 6:a0162952014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wiesinger M, Stoica D, Roessner S, Lorenz
C, Fischer A, Atreya R, Neufert CF, Atreya I, Scheffold A,
Schuler-Thurner B, et al: Good manufacturing practice-compliant
production and lot-release of ex vivo expanded regulatory T cells
as basis for treatment of patients with autoimmune and inflammatory
disorders. Front Immunol. 8:13712017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fletcher JM, Lonergan R, Costelloe L,
Kinsella K, Moran B, O'Farrelly C, Tubridy N and Mills KH:
CD39+Foxp3+ regulatory T cells suppress pathogenic Th17 cells and
are impaired in multiple sclerosis. J Immunol. 183:7602–7610. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gu J, Ni X, Pan X, Lu H, Lu Y, Zhao J, Guo
Zheng S, Hippen KL, Wang X and Lu L: Human CD39(hi) regulatory T
cells present stronger stability and function under inflammatory
conditions. Cell Mol Immunol. 14:521–528. 2017. View Article : Google Scholar : PubMed/NCBI
|
